Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with early diagnosis remaining a significant challenge.
Available serum biomarkers lack specificity, making it difficult to accurately identify early non-metastatic GC cases.
Reliable diagnostic biomarkers that can detect early GC are critical to improve prognosis.
